U.S. FDA has delayed abortion pill safety study, Bloomberg News reports

The U.S. Food and Drug Administration has delayed a review of safety data for the abortion drug mifepristone at Commissioner Marty Makary's request, Bloomberg News reported on Monday, citing people familiar with the matter.
Source